1. Rabeprazole suppresses cell proliferation in gastric epithelial cells by targeting STAT3-mediated glycolysis
- Author
-
Huiwen Li, Wanfu Xu, Huan Chen, Junhong Zhao, Defeng Liang, Yanhe Zhou, Lu Ren, Liya Xiong, Fangying Yang, Ling Huang, Peiyu Chen, Jiayu Chen, Sidong Chen, Peiqun Wu, Yuhua Zhang, Lanlan Geng, and Sitang Gong
- Subjects
Male ,STAT3 Transcription Factor ,0301 basic medicine ,Glucose uptake ,Rabeprazole ,Biochemistry ,Cell Line ,03 medical and health sciences ,Transactivation ,Drug Delivery Systems ,0302 clinical medicine ,medicine ,Gastric mucosa ,Humans ,Child ,STAT3 ,Cell Proliferation ,Pharmacology ,biology ,Chemistry ,Cell growth ,Epithelial Cells ,Anti-Ulcer Agents ,030104 developmental biology ,medicine.anatomical_structure ,Gastric Mucosa ,030220 oncology & carcinogenesis ,Cancer research ,STAT protein ,biology.protein ,Female ,Ectopic expression ,Glycolysis ,medicine.drug - Abstract
The dysregulation of glycolysis leads to serials of disease. Rabeprazole is a representative of proton pump inhibitors and widely used in anti-ulcer treatment. However, the function of Rabeprazole on glycolysis in gastric epithelial cells remained to be identified. In this study, 30(Helicobacter pylori)H. pylori-negative cases and 26H. pylori-positive cases treated with Rabeprazole were recruited. The qPCR and Western blotting results showed that Rabeprazole suppressed cell proliferation by inhibition of HK2-mediated glycolysis in BGC823 cells, leading to decrease glucose uptake and lactate production in a dose-dependent way. Furthermore, the phosphorylation of signal transducer and activator of transcription 3 (STAT3) was drastically reduced in response to Rabeprazole stimulation, leading to attenuate STAT3 nuclear translocation. Luciferase and Chromatin immunoprecipitation (ChIP) analysis showed that Rabeprazole treatment led to a significant inhibition of the binding of STAT3 to the promoter of the HK2 gene, repressing transcriptional activation of HK2. Moreover, the ectopic expression of STAT3 in BGC823 cells resulted in recovery of HK2 transactivation and cell proliferation in Rabeprazole-treated cells. Most importantly, HK2 expression was significantly increased in H. pylori-infected gastric mucosa. These findings suggested that Rabeprazole inhibited cell proliferation by targeting STAT3/HK2 signaling-mediated glucose metabolism in gastric epithelial cells. Therefore, targeting HK2 is an alternative strategy in improving the treatment of patients with H. pylori infection.
- Published
- 2021
- Full Text
- View/download PDF